SCHEMBL4521402

SCHEMBL4521402

BrCC#CCOc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.49
KCNA3 P22001 1/20 0.44
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
ALDH1A1 P00352 2/20 0.40
TAAR1 Q96RJ0 1/20 0.40
RECQL P46063 1/20 0.40
ALOX15 P16050 1/20 0.39
LTA4H P09960 1/20 0.38
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP13 P45452 1/20 0.37
KDM4E B2RXH2 1/20 0.37
EGFR P00533 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9808291 0.89 KCNH2 (0.57) KCNH2KCNA3CA12CA1CA2
Diphenylether SCHEMBL10632533 0.82 LTA4H (0.57) KCNH2KCNA3CA12CA1CA2
SCHEMBL10571938 0.80 KCNH2 (0.50) KCNH2KCNA3CA12CA1CA2
SCHEMBL27698936 0.80 KCNH2 (0.50) KCNH2KCNA3CA12CA1CA2
SCHEMBL1790840 0.79 KCNH2 (0.53) KCNH2KCNA3CA12CA1CA2
SCHEMBL3982634 0.78 TAAR1 (0.50) KCNH2KCNA3CA12CA1CA2
SCHEMBL7501197 0.78 KCNH2 (0.49) KCNH2KCNA3CA12CA1CA2
SCHEMBL14085300 0.78 KCNH2 (0.53) KCNH2KCNA3CA12CA1CA2
SCHEMBL5658625 0.78 ALDH1A1 (0.50) KCNH2KCNA3CA12CA1CA2
SCHEMBL4523232 0.76 LTA4H (0.45) KCNH2KCNA3LTA4HDRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7498460-B2 Isophthalic acid derivatives BAYER HEALTHCARE AG (DE) 2009-03-03 US disclosed
US-20060154912-A1 Isophtalic acid derivatives BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-07-13 US disclosed
US-4859229-A HERBICIDES HOFFMANN-LA ROCHE INC. (US) 1989-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154912-A1 Isophtalic acid derivatives VHL, FABP3, CPT1A KCNH2 1488/4885KCNA3 3486/4885CA12 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.